NEW! Investment Companies Centre
Virgin Credit Card:
There's a new Investor Edition of CMC Markets' spread betting platform... and it's exclusive to DigitalLook.com users...
Date: Monday 06 Oct 2008
LONDON (ShareCast) - Continuing efforts by hospitals to fight infections such as C. Difficile helped disinfectant supplier Tristel report sharp rises in profits and revenues.
Pre-tax profits in the year to June 30 rose to £1.2m from £787,000 over the same period a year ago as revenue climbed to £5.961m from £5.148m.
The rise in profits was largely due to an exceptional item in the previous year related to the ending of an agreement with another company. Turnover was boosted by increasing demand for newer products developed by Tristel.
“As we expand the applications of our chlorine dioxide technology, thereby creating new products for new uses and in new areas in hospitals, we increase our potential for revenue growth,” chief executive Paul Swinney said.
“In 2008 the surfaces and ultrasound products began to make their mark within UK hospitals.”
Tristel will pay a dividend of 1.55p for the full year, an increase of 15% from the previous year.